Skip to main content

Search

Clear
Filter by Type
Filter by Topics
Filter by Symptoms & Conditions
Filter by Year
Payment and Regulatory Update: September 22, 2021

Jul 21, 2021/Members Only

Topics discussed: Provider relief funding, vaccine mandates, DMEPOS, SNF and IRF final rules and commercial payer updates.

Identification and Management of Cardiometabolic Risk After Spinal Cord Injury

May 31, 2018/CPG

This guideline provides recommendations related to management of patients and cardiovascular risk post-spinal cord injury.

APTA's Leadership in Health and Wellness Recognized by HHS

Jan 20, 2023/News

The association is now a "Healthy People 2030 Champion," joining a nationwide, multi-organization network.

Aotearoa New Zealand Autism Spectrum Disorder Guideline: Third Edition

Jan 1, 2022/CPG

This guideline, from the New Zealand government, is for people with autism spectrum disorder (ASD), their families and carers, health and disability professionals, community supporters, employers, policy advisers, and anyone involved in education. Recommendations address diagnosis and initial assessment,

Bills To Expand Telehealth to PTs and PTAs Now in Both Senate and House

Nov 15, 2021/News

The Senate version of the Expanded Telehealth Access Act is helping to build momentum for change.

Educational Leadership Conference Focuses on Creating a Sustainable Future

Aug 20, 2021/News

The Oct. 22-24 event is built around the importance of developing habits than can ensure a strong future for physical therapy education.

Veterans Affairs and TRICARE

VA and TRICARE are major health systems in which PTs and PTAs play a major role. APTA can help you understand how they work.

What's New at ChoosePT.com: Expanded Consumer Info, Growing Directory of PTs

Jun 14, 2022/Roundup

APTA members benefit from millions of consumer visits and an enriched consumer-focused website. Here's what’s new.

Physical Therapy and Occupational Therapy Provide Significant Rehabilitative Value in Postacute Care

Apr 5, 2021/Statement

Study across 1.4 million Medicare cases indicates patients receiving these therapies have better quality of life and fewer hospital readmissions.